Guru Ownership Trend
Guru Analysis for Verona Pharma plc (VRNA)
Verona Pharma plc (VRNA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $291.98 M.
Top institutional holders include Stanley Druckenmiller and Renaissance Technologies.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $108.2 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies who increased their stake by 317.8%.
| Portfolio Manager | % Portfolio | Activity | Shares | Value | Report Date |
|---|---|---|---|---|---|
| 2.63% | 1,002,080 | $106.93 M | Q3 2025 | ||
| 0.09% | Add 317.8% | 615,900 | $65.72 M | Q3 2025 | |
| 0.07% | New Buy | 400,000 | $42.68 M | Q3 2025 | |
| 0.43% | New Buy | 285,185 | $30.43 M | Q3 2025 | |
| 0.08% | New Buy | 264,115 | $28.18 M | Q3 2025 | |
| 0.17% | New Buy | 163,800 | $17.48 M | Q3 2025 |
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Portfolio Manager | Option Type | % Portfolio | Activity | Shares | Value | Report Date |
|---|
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2025)
Guru Consensus (Q3 2025)
FAQs for Verona Pharma plc (VRNA)
Major holders include Stanley Druckenmiller ($106.93 M), Renaissance Technologies ($65.72 M), Paul Tudor Jones ($42.68 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 2.73 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $108.2 M, with 5 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited VRNA. The total reported sell value was $60.57 M.
Yes, 4 managers opened new positions in VRNA, and 1 increased their existing holdings. The total reported buy value was $168.77 M.